PodParley PodParley
PodParley
Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up: JAACAP July 2021 episode artwork

EPISODE · Jul 1, 2021 · 22 MIN

Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up: JAACAP July 2021

from Journal of the American Academy of Child and Adolescent Psychiatry · host Various

JAACAP July 2021: Contributing Editor Dr. Jung W. Kim interviews Drs. L. Eugene Arnold and Roger deBeus on if theta/beta-ratio (TBR) electroencephalographic biofeedback (neurofeedback [NF]) has a specific effect on attention-deficit/hyperactivity disorder (ADHD) beyond nonspecific benefit.

Episode metadata supplied by the publisher feed · Published Jul 1, 2021

Embed this episode

Ready to play

Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up: JAACAP July 2021

0:00 22:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of the American Academy of Child and Adolescent Psychiatry?

This episode is 22 minutes long.

When was this Journal of the American Academy of Child and Adolescent Psychiatry episode published?

This episode was published on July 1, 2021.

Can I download this Journal of the American Academy of Child and Adolescent Psychiatry episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!